Product/Composition:- | Fluticasone furoate + Vilanterol |
---|---|
Strength:- | 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol |
Form:- | Powder For Inhalation(DPI/MDI) |
Reference Brands:- | Breo Ellipta®(US), Relvar Ellipta® (EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Fluticasone furoate + Vilanterol, sold as Breo Ellipta® (U.S.) and Relvar Ellipta® (EU), is a once-daily inhalation therapy for asthma and COPD. It combines anti-inflammatory and bronchodilator action in strengths like 92/22 mcg and 184/22 mcg, delivered via the Ellipta® DPI. A top choice in respiratory care and pharma exports.
Fluticasone furoate and Vilanterol is a powerful once-daily combination therapy used for the long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). Marketed as Breo Ellipta® in the U.S. and Relvar Ellipta® in the EU, this inhalation powder combines Fluticasone, a corticosteroid that reduces inflammation, with Vilanterol, a long-acting beta-agonist (LABA) that relaxes airway muscles. Available in 92/22 mcg and 184/22 mcg strengths via the Ellipta® DPI, it offers 24-hour symptom control. Ideal for pharma B2B and export markets, this therapy enhances adherence and delivers effective respiratory relief with convenient once-daily dosing.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications